OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.

by Johan A Kers, Anthony W DeFusco, Jae H Park, Jin Xu, Mark E Pulse, William J Weiss, Martin Handfield
Published 2018-01-01

Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection

by Johan A. Kers, Robert E. Sharp, Anthony W. Defusco, Jae H. Park, Jin Xu, Mark E. Pulse, William J. Weiss, Martin Handfield
Published 2018-03-01

Treatment and Prevention of Recurrent <em>Clostridium difficile</em> Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model

by Hans-Jürgen Heidebrecht, William J Weiss, Mark Pulse, Anton Lange, Karina Gisch, Heike Kliem, Sacha Mann, Michael W. Pfaffl, Ulrich Kulozik, Christoph von Eichel-Streiber
Published 2019-02-01

Fluorocycline TP-271 Is Potent against Complicated Community-Acquired Bacterial Pneumonia Pathogens

by Trudy H. Grossman, Corey Fyfe, William O’Brien, Meredith Hackel, Mary Beth Minyard, Ken B. Waites, Jacques Dubois, Timothy M. Murphy, Andrew M. Slee, William J. Weiss, Joyce A. Sutcliffe, Mariana Castanheira
Published 2017-02-01

Immunopotentiation by Lymph-Node Targeting of a Malaria Transmission-Blocking Nanovaccine

by Gregory P. Howard, Gregory P. Howard, Nicole G. Bender, Prachi Khare, Borja López-Gutiérrez, Vincent Nyasembe, William J. Weiss, Jerry W. Simecka, Timothy Hamerly, Hai-Quan Mao, Hai-Quan Mao, Hai-Quan Mao, Hai-Quan Mao, Rhoel R. Dinglasan
Published 2021-08-01

Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis.

by Patrick D Olson, Lisa J Kuechenmeister, Kelsi L Anderson, Sonja Daily, Karen E Beenken, Christelle M Roux, Michelle L Reniere, Tami L Lewis, William J Weiss, Mark Pulse, Phung Nguyen, Jerry W Simecka, John M Morrison, Khalid Sayood, Oluwatoyin A Asojo, Mark S Smeltzer, Eric P Skaar, Paul M Dunman
Published 2011-02-01